PUBLISHER: Value Market Research | PRODUCT CODE: 2019576
PUBLISHER: Value Market Research | PRODUCT CODE: 2019576
Global Genomics Personalized Health Market Size, Share, Trends & Growth Analysis Report 2026-2034
The Genomics Personalized Health Market size is expected to reach USD 35.51 Billion in 2034 from USD 12.13 Billion (2025) growing at a CAGR of 12.67% during 2026-2034.
The global genomics personalized health market is witnessing rapid growth due to increasing adoption of precision medicine and advancements in genetic research. Personalized health solutions use genomic information to tailor treatments and preventive strategies for individuals. The rising prevalence of chronic diseases and the growing demand for targeted therapies are key factors driving market expansion. Additionally, advancements in sequencing technologies are enabling more accurate and affordable genomic analysis.
Key growth drivers include increasing investments in genomics research and the growing use of genetic testing in healthcare. The expansion of direct-to-consumer genetic testing services is also contributing to market growth. Furthermore, the integration of artificial intelligence and big data analytics is enhancing the interpretation of genomic data. The rising focus on preventive healthcare and early disease detection is supporting the adoption of personalized health solutions.
In the future, the genomics personalized health market is expected to grow significantly with continuous advancements in biotechnology and data analytics. The development of more precise and accessible genomic tools will further drive adoption. Emerging markets are likely to offer strong growth opportunities due to increasing healthcare investments. Additionally, ongoing research and innovation will expand the applications of genomics in healthcare.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Technology
- NGS Platform
- RT-PCR
- Microarray
- Genetic Analyzer
- Others
By Test Type
- Oncology Testing
- Infectious Disease Testing
- Orphan Disease Testing
- Autoimmune Disease Testing
- Obstetrics Testing
- Others
By End-user
- Academics & Research Institutes
- Diagnostic Centers
- Others
COMPANIES PROFILED
- QIAGEN, Illumina Inc, Thermo Fisher Scientific Inc, BioRad Laboratories Inc, HoffmannLa Roche AG, Lonza Group, Invitae Corp, Genetic Technologies Limited, Interleukin Genetics Inc, Eastern Biotech and Life Sciences, DNA Genotek Inc, uBiome Inc, XCode Life Sciences Private Limited
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Technology
- 4.2. NGS Platform Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. RT-PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Genetic Analyzer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY TEST TYPE 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Test Type
- 5.2. Oncology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Infectious Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Orphan Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Autoimmune Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Obstetrics Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY END-USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End-user
- 6.2. Academics & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Technology
- 7.2.2 By Test Type
- 7.2.3 By End-user
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Technology
- 7.3.2 By Test Type
- 7.3.3 By End-user
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Technology
- 7.4.2 By Test Type
- 7.4.3 By End-user
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Technology
- 7.5.2 By Test Type
- 7.5.3 By End-user
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Technology
- 7.6.2 By Test Type
- 7.6.3 By End-user
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL GENOMICS PERSONALIZED HEALTH INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 QIAGEN
- 9.2.2 Illumina Inc
- 9.2.3 Thermo Fisher Scientific Inc
- 9.2.4 Bio-Rad Laboratories Inc
- 9.2.5 Hoffmann-La Roche AG
- 9.2.6 Lonza Group
- 9.2.7 Invitae Corp
- 9.2.8 Genetic Technologies Limited
- 9.2.9 Interleukin Genetics Inc
- 9.2.10 Eastern Biotech And Life Sciences
- 9.2.11 DNA Genotek Inc
- 9.2.12 UBiome Inc
- 9.2.13 XCode Life Sciences Private Limited
